Vesicular stomatitis virus (VSV), the prototypic rhabdovirus, has been used as an excellent paradigm for understanding the mechanisms of virus replication, pathogenesis, host response to virus infection and also for myriads of studies on cellular and molecular biology. Biochemical studies as well as high-throughput genomics, proteomics, and chemical approaches have revealed a plethora of cellular factors and pathways that regulate replication of VSV. These factors include those that support virus replication and also those that restrict its replication. This chapter discusses the role(s) of many of these host cell factors and pathways involved in VSV replication. Although mechanistic understanding of the roles of some of these factors in VSV replication has been obtained, the roles of many others need to be investigated for a better understanding of the virus-host cell interactions.
Introduction
Vesicular stomatitis virus (VSV) is an enveloped, non-segmented negative stranded (NNS) RNA virus in the family Rhabdoviridae and order Mononegavirales. Members of the family have been classified into eleven genera primarily based on antigenicity and phylogenetic analyses.
1 Among them, the vesiculoviruses (prototype: VSV) and the lyssaviruses [prototype: rabies virus (RABV)] are the best characterized. Novel and emerging rhabdoviruses are continuously being identified and characterized (see chapter 13), many of which are yet to be classified due to lack of genome sequence information and low number of identified representative viruses in serogroups.
The two known serotypes of VSV [Indiana (VSV I ) and New Jersey (VSV NJ )] share many similar properties although differences have been reported.
2 VSV I is the most well characterized serotype. Its negative-sense RNA genome encodes 5 major proteins: the nucleocapsid protein (N), the phosphoprotein (P), the matrix (M), the glycoprotein (G) and the large polymerase protein (L). Inside the virion, the viral genome is tightly encapsidated with the N protein to form ribonucleocapsid complex (RNP or NC) with which the viral RNA dependent RNA polymerase (RdRp) complex of P-L proteins is associated. The G protein forms spikes on the surface of VSV virions and is responsible for attachment to host cells. Both M and G proteins are required for assembly and budding of infectious particles. Following entry by endocytosis, the G protein mediates fusion of the viral envelope with the endosomal membrane, thereby releasing the viral RNP into the cytoplasm. The RNP undergoes primary transcription by the associated RdRp to produce five capped and polyadenylated mRNAs, which are translated by the cellular translation machinery to generate the viral proteins for further steps in the infection process including genome replication, secondary transcription, virus assembly, and budding.
3 VSV has been used as a workhorse for studying virus replication mechanisms, pathogenesis, evolution, and virus-host interactions as well as understanding many aspects of cellular and molecular biology. With the development of the reverse genetics system in the early 1990's using a defective interfering (DI) particle of VSV, 4 recovery of infectious RABV and VSV soon followed. [5] [6] [7] Manipulation of full-length viral genomes and recovery of infectious viruses encoding a variety of foreign proteins have resulted in the use of these "designer viruses" as vaccine vectors (see chapter 9), as cancer therapeutics (chapter 10), and for myriads of studies on molecular and cellular biology of virus replication (chapters 3, 5, and 8) and pathogenic mechanisms (chapters 7 and 15). Since VSV has been widely recognized as a valuable research tool with promising applications, recent efforts have focused on understanding its interaction with host cells by identification of crucial host factors using high throughput genomics, proteomics, and chemical approaches. This chapter describes our current understanding of the role(s) of the host functions in VSV replication, with a focus on recent findings on the cellular factors and pathways that regulate various steps in the viral life cycle.
Host Functions Involved in Early Stages of VSV Infection

Attachment
Although VSV has been studied for over four decades, the key cellular factor(s) driving its pantropism has not been unequivocally identified. The low density lipoproteins (LDLs) 8 and the phospholipids, 9-11 in particular, phosphatidylserine (PS) 10 were described as molecules responsible for VSV attachment to host cells. Subsequent studies revealed that PS is unlikely to serve such a role, 12 although it may be involved in a post-binding steps of virus entry. Since the extent of G protein conformational change depends on the presence of PS on the target membrane and the rate of fusion reaction was remarkably increased when the PS content was increased, 13 the function of PS in VSV infection process may likely be to support a fusion step during the uncoating of viral RNPs. Other membrane lipids, like sialoglycolipids (gangliosides) but not asialoglycolipids (cerebrosides) were also implicated in the virus attachment to host cells. 14, 15 However, a recent study has identified the LDL receptor (LDLR) as the major receptor and other LDLR family members, as the alternative receptors for VSV entry. 16 LDLR family members are ubiquitously expressed in all cells and tissues across the animal kingdom and their specific interaction with the G protein may account for the pantropism of VSV.
16
In addition, VSV binding to the target membrane may further depend on electrostatic interactions between positive charges on the G protein and negatively charged phospholipids in the cellular membranes. 13, 17 The observation that removal of negatively charged polar head groups from these lipid molecules significantly reduces VSV attachment and fusion while the presence of polycation DEAE-dextran enhances VSV entry 18, 19 30, 32 suggesting that components of the ESCRT machinery are also required for the release of the viral RNPs into the cytoplasm from the endosomes.
Host Functions in Viral Macromolecular Synthesis
Viral mRNA Transcription
After release into the cytoplasm, the RNP template-associated viral RdRp complex performs primary transcription to produce the viral mRNAs from the input template. The mRNAs are translated to generate the viral proteins including N, P, and L proteins, which then carry out replication of the input viral genome to generate multiple progeny genomes. The newly synthesized negative-sense RNPs then undergo secondary transcription which amplifies the amount of viral mRNAs and proteins for further rounds of replication. Cyclophilin A (CypA), a chaperone protein possessing peptidyl cis-trans prolyl-isomerase activity, is required for primary transcription of VSV NJ genome but not the VSV I genome.
The enzymatic activity of CypA appears to be important, since its inhibition by cyclosporine A results in inhibition of primary transcription of VSV NJ by 85-90%. 35 Biochemical and mutational studies have shown that the viral RdRp involved in transcription is distinct from that involved in genome replication. Two distinct RdRp complexes have been isolated from infected cells and characterized. One complex, comprising of the viral L and P proteins along with the cellular guanylyltransferase, translation elongation factor 1α, and heat shock protein 60, was found to exclusively synthesize mRNAs and is thus called the viral transcriptase. The other complex, comprising of the viral L, P, and N proteins, synthesizes only the full-length encapsidated replication products and is termed the viral replicase.
36
Although the exact role of the cellular proteins in viral transcriptase complex is not known, they may facilitate viral transcription. Further studies are required to understand their role in VSV transcription. VSV mRNAs, like most eukaryotic mRNAs, are capped, methylated, and polyadenylated and these modifications are carried out by the viral RdRp (see chapter 5 for further details). Methylation of VSV mRNAs to form 5'-terminal structures is required for efficient translation in infected cells. Capping of the nascent transcripts is also important for transcription elongation and failure of correct 5' capping results in abortive transcription.
37
VSV RdRp executes the capping reaction differently by adding GDP instead of GMP (as seen in eukaryotic capping) to the viral mRNAs but not to the Le RNA. 38 Whether this unique mechanism of capping of the mRNAs by the viral RdRp is regulated by cellular and/or viral factors is not known but is of interest for identifying specific targets for therapeutic development. Phosphorylation by cellular protein kinases plays important roles in VSV infection not only during virus entry but also for viral gene expression. This was demonstrated by the effects on viral growth when the overall levels of protein phosphorylation were either enhanced or inhibited. 28, 39 The VSV P protein is a multifunctional protein that is phosphorylated by cellular kinase(s) for its function in viral genome transcription and replication. [40] [41] [42] [43] Although casein kinase II (CKII), a serine/threonine kinase, has been identified as one of the kinases involved in phosphorylation of P protein, [44] [45] [46] other kinases may also be involved as demonstrated by the use of inhibitors that do not affect CKII but block VSV RNA synthesis significantly. 39 With the recent identification of a tyrosine phosphorylation site in the P protein, 47 it is possible that other cellular kinase(s) may also mediate P phosphorylation for transcription and replication.
Viral Protein Synthesis
VSV mRNAs are translated in a cap-dependent manner by the host cells translation machinery. In the face of ongoing cellular mRNA translation, VSV usurps the translation machinery to preferentially translate its mRNAs via multiple mechanisms. The cellular eIF4F is a multisubunit complex involved in cap-dependent translation of host mRNAs. eIF4F regulates host translation through phosphorylation of cap-binding protein eIF4E, a subunit of the eIF4F complex. VSV infection leads to dephosphorylation of eIF4E and the translation inhibitor 4E-BP1 (eIF4E-binding protein 1), resulting in lower levels of eIF4F complex. Although the mechanism(s) by which VSV mediates these modifications is unknown at this time, this strategy allows the virus to subvert the cellular translation machinery for preferential translation of the viral mRNAs. 48 In addition, it appears that the cellular site of the transcription also contribute to the fate of the transcripts. Nascent viral mRNAs made in the cytoplasm are preferentially translated while translation of the host mRNAs is inhibited during VSV infection. 49, 50 VSV mRNA synthesis occurs throughout the host cell cytoplasm 51, 52 in inclusion bodies that contain the viral RNA synthesis machinery. 52 The mRNAs are transported from the inclusion bodies in a microtubule-dependent manner to the sites of translation. 52 VSV mRNAs do not contain cis-acting sequences that influence translation but they do contain cis-acting sequence-independent structural elements, which enhance translation efficiency of the viral mRNAs. 50 These structural elements may be utilized by cellular large ribosomal subunit protein rpL40 to facilitate formation of 80S ribosome on VSV mRNAs for translation. 53 rpL40 is required for cap-dependent translation of VSV, measles, and rabies virus mRNAs but not for cellular cap-dependent or internal ribosome entry site-driven mRNA translation. Thus, rpL40 is a host ribosomal protein that facilitates translation of mRNAs of several members of Mononegavirales, including VSV. Another mechanism by which VSV mRNAs are preferentially translated is by global shutdown of host transcription and translation through the viral M protein. The M protein interacts with the nuclear export pathway proteins Rae1 and Nup98 and thereby blocks the export of nascent cellular transcripts from the nucleus to the cytoplasm, resulting in shutoff of host protein synthesis. Studies have also implicated a role for the cellular La protein in VSV RNA replication. The La protein, which is normally associated with the pol III transcripts, was also shown to be specifically associated with the plus-strand and longest minus-strand (54 nt) leader RNAs in VSV-infected cells. 61, 62 The association correlated with enhancement in genome replication but the exact role of La protein, if any, remains to be deciphered.
Host Functions in VSV Assembly and Budding
VSV assembly occurs at the plasma membrane and is mediated by the viral M and G proteins. Current evidences indicate that VSV RNA and the individual proteins are transported to the plasma membrane via different routes. The G protein is synthesized in association with the ER where it is glycosylated and transported to the Golgi apparatus for processing of the glycan moieties and is finally transported to the plasma membrane. however in a separate study, dominant negative forms of both VPS4A and 4B were shown to inhibit VSV budding. 77 Nevertheless, the ESCRT machinery is required for scission of the viral membrane from the plasma membrane during budding (see chapter 8 for further details). In addition, the proteasomal pathway has been found to be indispensable for the virus budding. [77] [78] [79] The lipid composition of the membrane bilayer and lipid biogenesis may also play certain roles in the binding of M protein to the host cell membrane, since it was shown that triacylglycerol synthesis might interfere with virus maturation. 80 A recent mass-spec analysis of virion-associated proteins revealed a number of cellular proteins including integrin β1, HSP90, HSP cognate 71, annexin 2, EEF1A1 to have been packaged in the VSV virions. 81 These cellular proteins may potentially be involved in virus assembly, budding, and/or in other stages of virus infection processes. Functional studies of these proteins will be required to understand and appreciate their role in VSV life cycle.
Cellular Pathways that Regulate VSV Infection
In the previous sections, we described the role(s) of many individual host factors that facilitate or restrict VSV replication at various stages. Many of these factors appear to be involved in multiple steps of the viral life cycle. Cross-talk between various host factors and the pathways they represent also seems to be important for efficient multiplication or efficient restriction of replication of the virus. In several chapters of this book, the role(s) of many of these pathways in VSV infection have been described and the reader is directed to those chapters for further details. Although the list of factors and pathways that regulate VSV infection is by no means complete and will likely grow in the future, we describe below several of the major pathways and the associated factors that influence VSV replication.
Endocytic and Secretory Pathways
As described above (section 2.2), factors associated in CME are required for entry of VSV. The host proteins in the endocytic pathway and their roles in viral entry and nucleocapsid uncoating have been described in greater detail in chapter 3. The secretory pathway plays a critical role in VSV replication cycle. This pathway involves anterograde and retrograde transport of proteins and lipids, which are mediated by vesicles containing distinct sets of cytosolic coat protein complexes, the (COPII) and (COPI), respectively. 82, 83 Early studies revealed that the transport of VSV G from its site of synthesis in the ER to the Golgi and finally to the plasma membrane requires both COPII and COPI. 65 In these studies, the newly synthesized G protein was found to accumulate in COPII-containing vesicles at the ER, which then fuse to form larger transport complexes or ICs. In these ICs, the COPII is then replaced by COPI and the vesicles are then transported to the Golgi complex in a microtubule-dependent manner, thus suggesting a sequential mode of action of these two coatomer protein complexes in VSV G protein transport.
65
In addition to its role in G protein transport, the secretory pathway and, in particular, the COPI, also appears to play an important role in VSV gene expression. 84 The observations that (i)VSV gene expression is inhibited in COPI-depleted cells that are independent of the viral G protein processing and transport, (ii) pharmacologic inhibitors of COPI inhibit VSV gene expression as well as reduce viral RNA levels, (iii) viral gene expression requires the ADP ribosylation factor 1 (ARF1) and the Golgi-associated brefeldin A resistant factor 1 (GBF1), the two upstream effectors of COPI function, and (iv) VSV gene expression is reduced in nucleocapsid transfected cells that have been depleted of COPI strongly suggest a role for COPI function in viral RNA synthesis. 84 Additional evidence for the involvement of COPI in VSV RNA synthesis comes from studies using cells having a temperaturesensitive _-COP, a subunit of the heptameric COPI complex. 85 Mechanistically, whether the COPI complex is directly involved in regulating the viral polymerase functions or whether it may signal through downstream effectors essential for viral gene expression is not known at this time. VSV replicates throughout the cytoplasm of infected cells, 51,52 although the existence of specific replication organelles in the cytoplasm whose assembly requires COPI function cannot be ruled out. The requirement of COPI for genome replication has been well documented for positive-strand RNA viruses, which replicate in association with cytoplasmic membranous structures. 86 Further biochemical and ultrastructural studies in cells infected with VSV will likely illuminate the nature of the replication organelles, if any, for these viruses.
Innate Immune Signaling Pathways
Host cells survey invasive RNA viruses including VSV by the viral ssRNA, dsRNA or glycoproteins using either membrane-associated or cytosolic pattern recognition receptors (PRRs) to mount a well-orchestrated innate immune defense (see chapter 15 for further details). The membranous PRRs like toll-like receptor 4 (TLR4) present at the plasma membrane as well as TLR3, TLR7 and TLR8 in the endosomes, recognize the VSV glycoprotein (VSV-G) or RNA and transduce downstream antiviral signaling that culminates in the activation of transcription factors such as IFN regulatory factors 3 (IRF3), IRF7, IRF5 and/or nuclear factor κB (NF-κB), 87, 88 leading to the production of IFN and proinflammatory cytokines by the infected cells. Recently, TLR13, a novel member of the mammalian TLR family was reported to activate type I IFN production via activation of NF-κB and IRF7. 89 TLR13 seems to detect VSV at the surface of dendritic cells, macrophages or cells of the spleen where it is predominantly expressed. VSV RNP contributes to the early recognition of infection by the cytoplasmic PRRs consisting of the retinoic-acid-inducible gene I (RIG-I) and the melanoma differentiation-associated protein 5 (MDA5). RIG-I plays a major role in sensing VSV infection, since type I IFN production was found to be severely impaired in VSV infected RIG-I -/-MEFs compared to wild-type cells whereas MDA5 was dispensable.
90
PRR signaling results in production and secretion of IFN-α/β, which in autocrine or paracrine fashion, activate the JAK-STAT signaling pathway leading to synthesis of hundreds of interferon stimulated gene (ISG) products. Many ISGs, such as, phospholipase C (PLC) and phospholipase A2 (PLA2), 91 Recently, studies from our laboratory identified the interferon inducible protein IFI35 as a negative regulator of RIG-I antiviral responses during VSV infection. 108 IFI35 was found to interact with RIG-I and the RIG-I activity was attenuated through maintenance of its inactive, phosphorylated form and also through degradation of RIG-I by K-48-linked ubiquitination. 108 It appears that an intricate balance between the activities of various ISGs during VSV infection may modulate the outcome of the infection, although additional factors may also be involved. In recent years, autophagy has emerged as an important pathway complementing the innate immune pathways. Autophagy is an evolutionarily conserved mechanism in eukaryotes for degradation of unwanted intracellular cargo. Studies have shown autophagy to play an antiviral or proviral role depending on the virus and the host cell type.
109 For VSV, autophagy plays an antiviral role in the Drosophila model. 110 Recent studies have demonstrated that VSV infection induces autophagy in Drosophila cells via TLR-7-mediated recognition of VSV G protein from replication-competent VSV , UV inactivated (replication-incompetent) VSV or VSV-G harboring virus like particles (VLPs), suggesting the VSV G protein as the pathogen associated molecular pattern (PAMP) that stimulates the autophagy pathway. Interestingly, the AKT-mTOR axis involved in nutrient signaling also plays a role in activating the antiviral autophagy program. 111 In contrast, many positive sense RNA viruses like Dengue, Hepatitis C virus (HCV) and some DNA viruses like Kaposi sarcoma herpesvirus (KSHV) have been found to utilize autophagy as a proviral mechanism, which makes this pathway a necessary evil for the host in these cases.
109
Apoptotic and Cell Survival Pathways VSV infection initiates both intrinsic (mitochondrial) apoptosis through caspase-9 112 and extrinsic apoptosis through PKR, DAXX, and partly via Fas and caspase-8 113 (see chapter 7 for further details). Apoptosis can occur at an early stage of VSV life cycle without a requirement for RNA replication. 114 The apoptotic consequence is thought to be primarily due to viral M protein and leader RNA 115, 116 in addition to the alteration of levels of proteins in apoptotic pathways. 117, 118 The molecular mechanism for IFN to regulate VSV induced apoptosis is not clear yet but several signaling factors including STAT, 119,120 the ISGs such as PKR and OAS 121,122 and the apoptosis-inducing factor p53 123 appear to be involved.
In addition, cross-talk between apoptosis and innate immune response in VSV infection is responsible for induction of the intrinsic apoptotic pathway involving Bax-Caspase-9, which triggers phosphorylation of IRF3 and downstream type I IFN production.
124
Initiation of apoptosis by VSV M protein requires cellular factors and is cell-type dependent. Wt VSV induces faster apoptosis in HeLa cells than the mutant VSVM51R virus but it is the reverse in BHK-21 cells.
125 Consistent with this observation, we recently demonstrated a role for hnRNP K in supporting VSV infection through suppressing apoptosis induction and promoting survival of infected cells. 117 The studies revealed that hnRNP K helps maintain the low levels of expression of proapoptotic proteins such as BiK and Bcl-X S and high levels of expression of antiapoptotic proteins such as Bcl-X L , Bag1, and Bcl-2. 117 Additionally, hnRNP K supports expression of several cellular factors required for VSV replication and negatively regulates expression of cellular factors known to inhibit VSV replication. In particular, hnRNP K suppresses overall levels of total T-cell intracellular antigen 1 (TIA1) as well as expression of the TIA1b isoform (a differentially spliced form of TIA1a); both isoforms of TIA1 suppress VSV replication. 117, 126 Studies of the hnRNP K interactome revealed more than 100 interacting partners and determined that hnRNP K protein is present in the nucleus, cytoplasm, mitochondria, and the vicinity of the plasma membrane. 127 Thus, it is possible that hnRNP K exerts its positive impact on VSV growth through one or more of its interacting partners and may be involved in crosstalk between multiple pathways required for efficient VSV replication. The requirement of hnRNP K in VSV replication and the observation that hnRNP K levels in many cancerous cell types is upregulated may add to the understanding of why tumor cells provide an appropriate microenvironment (in addition to defective type I IFN response and signaling) for efficient VSV growth.
In contrast to the function of hnRNP K, hnRNPA1 plays a supporting role in VSV mediated apoptosis. 128 Studies have shown that VSV infection leads to a decrease of other antiapoptotic proteins such as keratinocyte transcription factor TP63 129 and myeloid cell leukemia 1 protein (Mcl-1), 130 while proapoptotic Bax was increased in the immortalized
HaCaT keratinocyte cell line. 129 miR-706 is upregulated in VSV infection and is able to inhibit VSV-induced apoptosis by decreasing caspase-3 and -9 activation, suggesting that induction of miR-706 expression may be a novel strategy for survival of VSV, allowing it to escape the apoptosis response of the host.
131
Akt/phosphatidylinositol-3-kinase (PI3K) pathway is a major cellular pathway controlling cell growth, proliferation, translation, and suppression of apoptosis. A variety of viruses are known to modulate this pathway. The observations that treatment of cells with Akt inhibitors significantly reduced VSV growth 132 and constitutively active Akt enhanced VSV replication 133 suggest that the Akt pathway is important in VSV replication.
However, conflicting data also exist as to the role of this pathway in viral replication. Akt is activated in macrophages infected with VSV and this leads to the inhibition of virus replication. 134 Similarly, inactivation of Akt also favors VSV replication in BHK-21 cells.
135
On the other hand, downregulation of Akt in Drosophila suppresses VSV replication.
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RNA Interference (RNAi) Pathway
The cellular RNA interference (RNAi) pathway, which is an innate immune defense mechanism to control viral infections in plants and insects, is also involved in regulating VSV infection. This was first demonstrated in the worm Caenorhabditis elegans. 136, 137 Cells derived from mutant worms defective in the RNAi response supported higher levels of VSV replication as compared to the cells from the wild-type counterpart indicating that the RNAi pathway controls replication of VSV. 136, 137 In Drosophila, RNAi-mediated response also confers protection against infection by VSV. 138, 139 Depletion of the arsenite resistance protein 2 (Ars2), which is required for siRNA-and miRNA-mediated silencing, results in increased replication of VSV in Drosophila cell cultures and adult flies. 139 The RNAi pathway has been shown to be inducible by IFN 140 and thus constitutes another arm of the innate host defense against a variety of virus infections in vitro 141 and in vivo. 142 Mice hypomorphic for Dicer, the endoribonuclease that catalyzes production of siRNAs and miRNAs, are more sensitive to VSV infection due to impairment in production of miR24 and miR93, 143 highlighting an important role for miRNAs in antiviral defense against VSV in mammalian systems. The miR93 and miR24 target the viral mRNAs for the P and L proteins, respectively, and thus suppress VSV replication. The cellular RNAi pathway also participates in controlling the appropriate response of innate immunity to VSV infection. Some miRNAs such as miR-146a and miR-466l negatively regulate type I IFN responses and support VSV infection. 144, 145 Thus, the important role of the RNAi pathway in regulating VSV replication is being increasingly appreciated.
ESCRT Pathway
The ESCRT pathway is intimately involved in steps during virus entry as well in virus assembly and exit from the cells. The specific role(s) of various ESCRT subunits in the VSV life cycle has been detailed in chapters 3 and 8.
Stress Response Pathway
The crosstalk between stress induced responses and cellular innate immunity has been established in cellular responses to suppress VSV infection. It is known that VSV infection induces both oxidative stress and an anti-oxidative response in mammalian cells.
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Stressful conditions such as viral infections, hypoxia, heat shock, UV irradiation, amino acid starvation or oxidative stresses induced by arsenite treatment can activate one or more of the five putative eIF2α kinases (PERK, GCN2, PKR, A functional proteasome pathway also seems to be important for VSV protein synthesis since proteasome inhibitors significantly suppress viral protein synthesis through stimulation of stress-related responses such as phosphorylation of eIF2α. 150 The host protein, REgulated in Development and DNA Damage responses 1 (REDD1), which is usually induced in cells undergoing ER stress, 151 is initially induced at early stages of VSV infection but quickly decreases back to normal levels at 4 hpi due to the global suppression of translation by VSV M protein. 152 The demonstration of antiviral activity by the small molecules, nephthalimides, through upregulation of REDD1 and concomitant inhihition of mTORC1 suggest that mTORC1 plays an important role in regulation of VSV replication. The requirement for activation of mTORC1 for VSV infection appears to be for viral mRNA translation. 152 In addition to its role in translational control, mTORC1 is known to stimulate type I IFN production through phosphorylation of p70S6K and 4E-BP1. 153, 154 These findings suggest that exploitation of mTORC1 pathway may be another mechanism that VSV employs to facilitate viral mRNAs translation. However, the apparent paradoxical effects of mTORC1 activation on stimulation of IFN production and upregulation of VSV replication needs further investigation to help clarify and determine the mechanistic involvement of mTORC1 in VSV replication.
Other Factors and Pathways
Post-translational modifications such as glycosylation, phosphorylation, ubiquitination, SUMOylation, ISGylation, etc, affect the maturation of viral proteins and thus regulate VSV replication. These modifications also influence activities of many host cell proteins that regulate VSV infection. Prostaglandin A1 (PGA1) and the delta12-Prostaglandin J2 (delta 12-PGJ2), a naturally occurring dehydration product of prostaglandin D2, inhibit VSV growth via suppression of synthesis and post-translational glycosylation of G protein.
155,156
The activity of VSV P and M proteins are also affected by type I IFN in neuronal cells, whereP is hypophosphorylated and M is hyperphosphorylated. Hypophosphorylated P may affect VSV replication and transcription 40-43 whereas hyperphosphorylated VSV M protein inhibits its association with VSV nucleocapsid. 157 These studies suggest a possible mechanism for type I IFN-mediated misassembly through disruption of the interactions between viral RNP and the M protein. 157 The VSV M is ubiquitinated by Rsp5 ubiquitin ligase and thus may play a role in virus assembly and budding.
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The hnRNPU, a protein involved in pre-mRNA processing, specifically interacts with the VSV leader RNA in the nuclei and colocalizes with the viral RNP in the cytoplasm. hnRNPU is also packaged within purified VSV virions 158 but its role in the viral life cycle remains to be examined. In contrast, PCBP1 and PCBP2, cellular regulators of splicing, transcription, translation, and mRNA stability, interact with VSV P and function as negative regulators of virus gene expression. 97 Further studies reveal that TIA1, a PCBP2-interacting partner and a critical factor for stress granule formation, 147,159 also functions as a negative regulator of VSV gene expression.
126
The PI3K/Akt/NF-κB pathway requires the presence of Grb2-associated binder 1 (Gab1), a member of scaffolding/adaptor proteins, to protect macrophages from VSV infection.
160 Akt1 phosphorylates and inactivates the transcription repressor EMSY, resulting in its inability to bind to ISG promoters, leading to the expression of ISGs and inhibition of VSV growth. 161 The protein arginine N-methyltransferase (PRMT1) specifically binds to the intracytoplasmic domain of the type I IFN receptor to transduce the antiviral signaling mediated by IFN-β. 162 The involvement of PKC in the antiviral response to VSV infection mediated by hormone oxytoxin in human amnion cells 163 of upregulation of NOS-1 and increased NO production in neuronal cells. 171 In cells of the reticuloendothelial system, IFN-γ treatment induces the expression of a set of low molecular weight MHC-encoded proteins (LMPs), which replace the beta-subunit of the proteasome complex during the proteasome neosynthesis, resulting in an antiviral complex termed the immunoproteasome in neuronal cells 171 that restricts VSV replication.
Concluding Remarks and Future Perspectives
VSV requires many cellular factors and pathways for efficient replication in host cells. Likewise, the host cells respond to VSV infection by expressing and/or activating factors and pathways to restrict virus replication. It is the net effect of these opposing factors/ pathways that likely determines the outcome of the virus infection. As discussed above, mechanistic understanding of many factors that regulate VSV infection has been achieved; however, our current understanding of the role(s) of many others remains elusive. At this time, two genome-wide siRNA screens, 84,172 a kinome screen for the endocytic pathway 29 and at least two antiviral small molecule screens 152,173 have revealed many interesting cellular factors that regulate VSV infection at multiple stages in the viral life cycle (Fig.  1) . Understanding of the role(s) of these proteins and cross-talk between them and the cellular pathways involved in the VSV life cycle is of paramount significance for a better understanding of VSV-host cell interactions. VSV is not only used as a model pathogen for understanding the mechanisms of replication and pathogenesis of this class of viruses, it is also used as a vaccine vector and an oncotherapeutic agent. Therefore, a complete understanding of VSV-host interactions will also be crucial for development of more efficacious vaccine vectors and oncolytic VSV.
